PET-CT is widely recommended in international clinical guidelines, including those of the European Association of Nuclear ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...

A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image ...

New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...

The Clatterbridge Cancer Centre in Wirral has installed the UK’s first Siemens Biograph Trinion PET-CT scanner, offering faster, advanced ...

The evolving utilization of functional imaging, mainly 2-[18 F]fluoro-2-deoxyglucose (18 FDG) imaging, with positron emission tomography (PET) and PET/CT, is profoundly altering head and neck tumor ...